In 2019, the national fiscal revenue exceeded 19 trillion yuan
According to data released by the Ministry of Finance on the 10th, in 2019, the national general public budget revenue was 19038.2 billion yuan, up 3.8% year on year. Among them, the central general public budget revenue was 8930.5 billion yuan, an increase of 4.5% year on year; the local general public budget revenue was 10107.7 billion yuan, an increase of 3.2% year on year. Data shows that in 2019, the national tax revenue is 15799.2 billion yuan, an increase of 1% year on year; the non tax revenue is 3239 billion yuan, an increase of 20.2% year on year.
2026-09-23
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Granja holdings Hengrui 40 million shares
-
WuXi AppTec: Second-quarter Revenue Still Expected to Grow 63% to 65%
-
Dow's Revenue And Profit Double
-
2020/21 chemical industry earnings expectations are lowered
-
Daily chemical leader Shanghai Jahwa's daily limit, Q1 net revenue decline
-
The national fiscal revenue increased by 3.3% year on year
-
Shanxi Coking: net profit in the first three quarters decreased by 30%
-
The operating revenue of cultural and related industries above designated size
-
After IPO, the profit of yujiahui in the first 3 quarters fell by more than 90%
-
Yhe revenue of state-owned enterprises increased by 7.1%
Recommend Reading
-
Japan Extends Bisphenol A Anti-Dumping Probe, Prolonging Uncertainty for Korean and Taiwanese Suppliers
-
US Tariff Refunds Could Reshape Seafood Trade
-
Hormuz Closure Raises Cold-Chain Risk
-
Hormuz Closure Raises Cold-Chain Risk
-
Lianolong Bets Big on Electronic Adhesives with $50M Strategic Stake in Sidofu
-
This Week's Hydrogen Fluoride Market Remains Steady (12.1-12.5)
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
India Approves ₹30.3 Billion Chemical-Park Scheme to Build Three Mega Industrial Hubs
-
EFSA’s Updated Food-Additive Application Guidance Takes Effect
-
FDA Revokes Orange B Authorization and Proposes Removing Citrus Red No. 2